Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)

NCT02616666 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT02616666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02616666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)
Lead sponsor
University of Liverpool
Phase
Phase 4
Overall status
Completed
Start date
August 25, 2016
Completion date
December 12, 2025
Enrollment
632 (actual)
Sites
132

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus